These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

651 related items for PubMed ID: 10573518

  • 1. Cholangiocarcinomas express Fas ligand and disable the Fas receptor.
    Que FG, Phan VA, Phan VH, Celli A, Batts K, LaRusso NF, Gores GJ.
    Hepatology; 1999 Dec; 30(6):1398-404. PubMed ID: 10573518
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of CD95 apoptotic signaling by interferon-gamma in human osteoarthritic chondrocytes is associated with increased expression of FLICE inhibitory protein.
    Grassi F, Piacentini A, Cristino S, Toneguzzi S, Facchini A, Lisignoli G.
    Arthritis Rheum; 2004 Feb; 50(2):498-506. PubMed ID: 14872492
    [Abstract] [Full Text] [Related]

  • 3. Reciprocal co-expression of Fas and Fas ligand in human cholangiocarcinoma.
    Pan G, Ahn EY, Chen Y, Feng G, Reddy V, Jhala NC, McDonald JM.
    Int J Oncol; 2007 Oct; 31(4):843-50. PubMed ID: 17786316
    [Abstract] [Full Text] [Related]

  • 4. Up-regulation of fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillance.
    Shimonishi T, Isse K, Shibata F, Aburatani I, Tsuneyama K, Sabit H, Harada K, Miyazaki K, Nakanuma Y.
    Hepatology; 2000 Oct; 32(4 Pt 1):761-9. PubMed ID: 11003620
    [Abstract] [Full Text] [Related]

  • 5. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
    Fulda S, Meyer E, Debatin KM.
    Cancer Res; 2000 Jul 15; 60(14):3947-56. PubMed ID: 10919673
    [Abstract] [Full Text] [Related]

  • 6. Expression level of c-FLIP versus Fas determines susceptibility to Fas ligand-induced cell death in murine thymoma EL-4 cells.
    Kataoka T, Ito M, Budd RC, Tschopp J, Nagai K.
    Exp Cell Res; 2002 Feb 15; 273(2):256-64. PubMed ID: 11822881
    [Abstract] [Full Text] [Related]

  • 7. Human CD34+ hematopoietic stem/progenitor cells express high levels of FLIP and are resistant to Fas-mediated apoptosis.
    Kim H, Whartenby KA, Georgantas RW, Wingard J, Civin CI.
    Stem Cells; 2002 Feb 15; 20(2):174-82. PubMed ID: 11897874
    [Abstract] [Full Text] [Related]

  • 8. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.
    Ungefroren H, Voss M, Jansen M, Roeder C, Henne-Bruns D, Kremer B, Kalthoff H.
    Cancer Res; 1998 Apr 15; 58(8):1741-9. PubMed ID: 9563493
    [Abstract] [Full Text] [Related]

  • 9. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
    Sylvester PW, Shah S.
    Asia Pac J Clin Nutr; 2005 Apr 15; 14(4):366-73. PubMed ID: 16326643
    [Abstract] [Full Text] [Related]

  • 10. FR901228 induces tumor regression associated with induction of Fas ligand and activation of Fas signaling in human osteosarcoma cells.
    Imai T, Adachi S, Nishijo K, Ohgushi M, Okada M, Yasumi T, Watanabe K, Nishikomori R, Nakayama T, Yonehara S, Toguchida J, Nakahata T.
    Oncogene; 2003 Dec 18; 22(58):9231-42. PubMed ID: 14647441
    [Abstract] [Full Text] [Related]

  • 11. COX-2 inhibits Fas-mediated apoptosis in cholangiocarcinoma cells.
    Nzeako UC, Guicciardi ME, Yoon JH, Bronk SF, Gores GJ.
    Hepatology; 2002 Mar 18; 35(3):552-9. PubMed ID: 11870367
    [Abstract] [Full Text] [Related]

  • 12. Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing.
    Poulaki V, Mitsiades CS, McMullan C, Fanourakis G, Negri J, Goudopoulou A, Halikias IX, Voutsinas G, Tseleni-Balafouta S, Miller JW, Mitsiades N.
    Invest Ophthalmol Vis Sci; 2005 Jan 18; 46(1):358-66. PubMed ID: 15623796
    [Abstract] [Full Text] [Related]

  • 13. Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes.
    Gastman BR, Atarshi Y, Reichert TE, Saito T, Balkir L, Rabinowich H, Whiteside TL.
    Cancer Res; 1999 Oct 15; 59(20):5356-64. PubMed ID: 10537320
    [Abstract] [Full Text] [Related]

  • 14. [The "Fas counterattack": a mechanism for immune evasion in human hilar cholangiocarcinomas].
    Li Z, Zhang L, Zou S.
    Zhonghua Yi Xue Za Zhi; 2002 May 10; 82(9):606-9. PubMed ID: 12133481
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.
    Herr I, Ucur E, Herzer K, Okouoyo S, Ridder R, Krammer PH, von Knebel Doeberitz M, Debatin KM.
    Cancer Res; 2003 Jun 15; 63(12):3112-20. PubMed ID: 12810637
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Apoptosis induced by a chimeric Fas/FLICE receptor: lack of requirement for Fas- or FADD-binding proteins.
    Memon SA, Hou J, Moreno MB, Zacharchuk CM.
    J Immunol; 1998 Mar 01; 160(5):2046-9. PubMed ID: 9498739
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.